|
Market Closed -
Nasdaq
01:30:00 17/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.630 USD | +20.64% |
|
+234.69% | -18.58% |
| 16/10 | Top Premarket Gainers | MT |
| 14/10 | Alaunos Therapeutics Enters into Agreement and Plan of Merger with Velaris Therapeutics | CI |
| Market Cap | 66.81L 59.39L 55.05L 50.08L 94.51L 63Cr 96.03L 6.62Cr 2.59Cr 33Cr 2.51Cr 2.45Cr 105.49Cr | P/E 2024 |
-0.65x | P/E 2025 | -1.47x |
|---|---|---|---|---|---|
| Enterprise Value | 52.96L 47.08L 43.64L 39.7L 74.92L 50Cr 76.12L 5.25Cr 2.06Cr 26Cr 1.99Cr 1.95Cr 84Cr | EV / Sales 2024 |
19,59,38,500x | EV / Sales 2025 | 1,16,47,61,400x |
| Free-Float |
86.79% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TCRT | Delayed | |
CBOE
| TCRT | Real-time |
| 1 day | +20.64% |
| Manager | Title | Age | Since |
|---|---|---|---|
Holger Weis
CEO | Chief Executive Officer | 63 | 02/07/2025 |
| Director of Finance/CFO | 42 | 22/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Jaime Vieser
BRD | Director/Board Member | 56 | 16/12/2020 |
Holger Weis
CHM | Chairman | 63 | 22/09/2023 |
Robert Postma
BRD | Director/Board Member | 72 | 05/02/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/10/26 | Free | Chief Executive Officer | 23,564 | 0.9275% | ||
| 06/10/26 | Free | Director | 22,669 | 0.8923% | ||
| 06/10/26 | Free | Director | 21,829 | 0.8592% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +20.64% | +234.69% | - | - | 66.81L | |
| -6.60% | -8.56% | +49.38% | +63.51% | 6.5TCr | |
| +0.03% | +5.56% | +9.10% | +69.05% | 5.12TCr | |
| -4.09% | -0.11% | +2.22% | +53.15% | 5.12TCr | |
| -1.53% | +2.70% | +30.48% | +34.12% | 4.39TCr | |
| -1.34% | +4.12% | +16.64% | +115.13% | 4.2TCr | |
| -5.97% | -6.22% | +228.95% | +454.22% | 3.81TCr | |
| +6.53% | +8.02% | +16.40% | +53.41% | 3.32TCr | |
| -0.90% | -10.49% | +37.09% | -3.70% | 2.52TCr | |
| -1.07% | +2.33% | +19.43% | +9.98% | 2.25TCr | |
| Average | +0.57% | +23.15% | +45.52% | +94.32% | 3.72TCr | |
| Weighted average by Cap. | -2.20% | -0.49% | +44.25% | +96.53% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.01 0.01 0.01 0.01 0.01 0.95 0.01 0.1 0.04 0.5 0.04 0.04 1.58 | 0 0 0 0 0.01 0.47 0.01 0.05 0.02 0.25 0.02 0.02 0.79 |
| Net income | -46.79L -41.59L -38.55L -35.07L -66.19L -44Cr -67.25L -4.63Cr -1.82Cr -23Cr -1.76Cr -1.72Cr -74Cr | -41.76L -37.12L -34.41L -31.3L -59.07L -40Cr -60.02L -4.14Cr -1.62Cr -21Cr -1.57Cr -1.53Cr -66Cr |
| Net Debt | -10.91L -10L -9L -8L -15.43L -10Cr -15.68L -1.08Cr -42.36L -5.4Cr -40.95L -40.07L -17Cr | -13.85L -12.31L -11.41L -10.38L -19.59L -13Cr -19.91L -1.37Cr -53.78L -6.86Cr -51.98L -50.87L -22Cr |
Employees
1
| Date | Price | Change |
|---|---|---|
| 16/26/16 | $2.630 | +20.64% |
| 15/26/15 | $2.180 | +5.31% |
| 14/26/14 | $2.070 | -31.68% |
| 13/26/13 | $3.030 | +188.57% |
| 12/26/12 | $1.050 | +33.62% |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- TCRT Stock
Select your edition
All financial news and data tailored to specific country editions
